Subtopic Deep Dive

Radiation Recall Dermatitis from Chemotherapy
Research Guide

What is Radiation Recall Dermatitis from Chemotherapy?

Radiation recall dermatitis is an acute inflammatory skin reaction confined to previously irradiated areas triggered by subsequent chemotherapy administration.

This phenomenon involves localized erythema, edema, and desquamation in prior radiation fields after drugs like anthracyclines or taxanes. Burris and Hurtig (2010) describe it as poorly understood with over 300 citations. Friedlander et al. (2004) note most reactions are cutaneous, with 95 citations.

15
Curated Papers
3
Key Challenges

Why It Matters

Radiation recall dermatitis complicates multimodal cancer therapy by necessitating chemotherapy dose adjustments or delays, impacting treatment efficacy (Burris and Hurtig, 2010). It affects patient quality of life through painful skin reactions requiring dermatological management (Fabbrocini et al., 2012). Yeo and Johnson (2000) highlight associations with antineoplastic drugs, guiding safer sequencing of radiotherapy and chemotherapy.

Key Research Challenges

Unclear Pathogenesis

Mechanisms remain poorly understood despite recognition since 1974. Donaldson et al. (1974) first reported adriamycin triggering recall, but cellular processes are undefined. Burris and Hurtig (2010) emphasize need for molecular studies.

Predicting Incidence

Risk factors like radiation dose and chemotherapy timing vary unpredictably. Friedlander et al. (2004) found gemcitabine recall more internal than cutaneous. No reliable predictive models exist across agents.

Management Strategies

Optimal interventions like corticosteroids lack standardization. Bray et al. (2016) review acute reactions but specific recall protocols are absent. Guillot et al. (2004) note diverse mucocutaneous effects complicating care.

Essential Papers

1.

Acute and Chronic Cutaneous Reactions to Ionizing Radiation Therapy

Fleta N. Bray, Brian J. Simmons, Aaron H. Wolfson et al. · 2016 · Dermatology and Therapy · 368 citations

2.

Radiation Recall with Anticancer Agents

Howard A. Burris, Jane Hurtig · 2010 · The Oncologist · 319 citations

Abstract Radiation recall is an acute inflammatory reaction confined to previously irradiated areas that can be triggered when chemotherapy agents are administered after radiotherapy. It remains a ...

3.

Adriamycin Activating a Recall Phenomenon After Radiation Therapy

Sarah S. Donaldson, JANE M. GLICK, JORDAN R. WILBUR · 1974 · Annals of Internal Medicine · 164 citations

Letters1 September 1974Adriamycin Activating a Recall Phenomenon After Radiation TherapySARAH S. DONALDSON, M.D., JANE M. GLICK, PH.D., JORDAN R. WILBUR, M.D.SARAH S. DONALDSON, M.D.Search for more...

4.

Chemotherapy and skin reactions

Gabriella Fabbrocini, Norma Cameli, Maria Concetta Romano et al. · 2012 · Journal of Experimental & Clinical Cancer Research · 98 citations

Oncological therapies have become more selective and have low systemic toxicity because of their high specificity, but cutaneous side effects are common and may worsen the quality of life of these ...

5.

Gemcitabine‐related radiation recall preferentially involves internal tissue and organs

Philip Friedlander, Roopa Bansal, Lawrence B. Schwartz et al. · 2004 · Cancer · 95 citations

Abstract Radiation recall refers to inflammatory reactions triggered by cytotoxic agents and develops in previously irradiated areas. Most reactions develop cutaneously. The most common chemotherap...

6.

Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer

Xiao Ding, Wei Ji, Junling Li et al. · 2011 · Radiation Oncology · 82 citations

Abstract Background Radiation recall pneumonitis (RRP) describes a rare reaction in previously irradiated area of pulmonary tissue after application of triggering agents. RRP remains loosely charac...

Reading Guide

Foundational Papers

Start with Burris and Hurtig (2010, 319 citations) for core definition and review, then Donaldson et al. (1974, 164 citations) for historical adriamycin case establishing the phenomenon.

Recent Advances

Study Bray et al. (2016, 368 citations) for acute reaction management and Cousin et al. (2021, 71 citations) on immune checkpoint inhibitor recall.

Core Methods

Literature relies on case series (Donaldson 1974), reviews (Burris 2010), and observational incidence studies (Friedlander 2004); no RCTs due to rarity.

How PapersFlow Helps You Research Radiation Recall Dermatitis from Chemotherapy

Discover & Search

Research Agent uses searchPapers with query 'radiation recall dermatitis chemotherapy' to retrieve Burris and Hurtig (2010, 319 citations), then citationGraph reveals Donaldson et al. (1974) as foundational predecessor and findSimilarPapers uncovers Friedlander et al. (2004) on gemcitabine-specific recall.

Analyze & Verify

Analysis Agent applies readPaperContent to extract incidence data from Fabbrocini et al. (2012), verifies claims via verifyResponse (CoVe) against Bray et al. (2016), and runPythonAnalysis with pandas to statistically compare citation impacts and reaction rates across 10 papers, graded by GRADE for evidence strength.

Synthesize & Write

Synthesis Agent detects gaps in pathogenesis studies post-2010, flags contradictions between cutaneous vs. internal recall (Friedlander et al., 2004), while Writing Agent uses latexEditText for drafting reviews, latexSyncCitations for Burris (2010), and latexCompile for publication-ready manuscripts with exportMermaid timelines of drug-radiation interactions.

Use Cases

"Analyze incidence rates of radiation recall dermatitis from anthracyclines across studies"

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas aggregation of rates from Donaldson 1974, Burris 2010) → CSV export of meta-analysis table.

"Draft LaTeX review on gemcitabine radiation recall mechanisms"

Synthesis Agent → gap detection → Writing Agent → latexEditText (intro from Friedlander 2004) → latexSyncCitations → latexCompile → PDF with cited bibliography.

"Find code for simulating radiation recall risk models"

Research Agent → paperExtractUrls (from recent toxicity papers) → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis on risk prediction scripts.

Automated Workflows

Deep Research workflow scans 50+ papers via exaSearch on 'radiation recall chemotherapy skin', structures report with GRADE-graded evidence from Burris (2010) and Friedlander (2004). DeepScan applies 7-step CoVe chain to verify mechanisms in Donaldson (1974) against Bray (2016). Theorizer generates hypotheses on taxane triggers from citationGraph clusters.

Frequently Asked Questions

What defines radiation recall dermatitis?

It is an acute inflammatory reaction in previously irradiated skin triggered by chemotherapy, as defined by Burris and Hurtig (2010).

What chemotherapy agents cause it?

Anthracyclines like adriamycin (Donaldson et al., 1974) and gemcitabine (Friedlander et al., 2004) are common triggers.

What are key papers?

Burris and Hurtig (2010, 319 citations) reviews mechanisms; Donaldson et al. (1974, 164 citations) reports first adriamycin case.

What open problems exist?

Pathogenesis unclear and predictive models lacking, per Burris and Hurtig (2010) and Friedlander et al. (2004).

Research Chemotherapy-related skin toxicity with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Radiation Recall Dermatitis from Chemotherapy with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers